Indian startup brings pregnancy AI solutions to rural Vietnam, Laos
Women’s health startup Doto Health from India has entered into a strategic partnership to expand across Southeast Asia.
It signed a memorandum of understanding with human development organisation FHI 360, Alive & Thrive, which is a global program focused on mother, child, and youth nutrition, and the Health Departments of Quang Tri in Vietnam and Savannakhet and Salavan in Laos to promote the adoption of digital health solutions in addressing challenges in maternal and infant mortality.
Doto Health’s CareMother brand offers AI-powered pregnancy care solutions, one of which, a wireless foetal monitor, was recently demonstrated at the Dakrong District Hospital in Quang Tri.
Leveraging AI-powered technologies, the partnership will enable point-of-care diagnostics, remote monitoring, and data-driven decision-making to enhance pregnancy care, especially in underserved areas.
Korea OKs Vuno’s ECG-based kidney failure screening software
Medical AI company VUNO has obtained regulatory approval from the South Korean government for its AI-based ECG analysis software for screening renal dysfunction.
According to a media release, DeepECG Kidney is the first locally developed solution of its kind to be approved by the Ministry of Food and Drug Safety (MFDS).
It analyses 12-lead ECG data using deep learning to noninvasively screen for kidney failure indicative of chronic kidney disease. It has demonstrated up to 85% screening accuracy in a clinical study.
The kidney failure screening software is the fourth in VUNO’s lineup of ECG-based analysis products to receive an MFDS clearance. The other solutions are indicated for screening acute myocardial infarction, left ventricular systolic dysfunction, and hyperkalemia.
Additionally, VUNO disclosed its plan to link the software, along with its other ECG-based analysis software, to the portable ECG measurement device, HATIV P30.
Singaporean insurtech startup rakes in $147M Series C funding
Singapore-based insurance technology startup bolttech has raised $147 million in Series C funding from big investors, including Japanese conglomerate Sumitomo Corporation and Iberis Capital from Portugal.
Now valued at $2.1 billion, bolttech looks to accelerate its global expansion using its fresh funds.
Alongside the investment, Sumitomo also agreed to set up a joint venture with the insurtech startup to offer insurance programmes and complementary end-to-end services for its partners across Asia. The trading company has businesses in metals, transportation, environment, media, mineral resources, energy, chemicals, electronics, and lifestyle-related goods and services.
Sinopharm to distribute XR-based surgery glasses
MediThinQ, a South Korean medical equipment manufacturer, is set to enter the Chinese market after signing an exclusive distribution deal.
Chinese state-owned pharmaceutical giant Sinopharm agreed to be its exclusive partner in distributing its wearable extended reality-based surgical equipment called Scopeye across major hospitals in China.
The MediThinQ glasses, which have regulatory approvals in South Korea, Europe, and the United States, deliver high-definition visualisation of images and information directly to the surgeon’s eyes during live procedures.
